Pharmaceutical Manufacturing of Moxifloxacin Hydrochloride Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency within the Department of Defense is seeking a subcontractor for the pharmaceutical manufacturing of Moxifloxacin Hydrochloride Tablets. The scope of work involves cGMP-compliant manufacturing, formulation, and quality control testing to ensure all products meet both military and FDA standards. This opportunity falls under NAICS code 325412 and was posted on August 25, 2026. Interested parties must submit their responses by the deadline of August 31, 2026.
General Info
Agency
NAICS
Place of Performance
USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-4755.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
MOXIFLOXACIN HYDROCHLO
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
